(IBM) International Business - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4592001014
IBM: Software, Consulting, Infrastructure, Financing
IBM, a global leader in technology and consulting, operates through four key segments: Software, Consulting, Infrastructure, and Financing. The Software segment offers hybrid cloud and AI platforms, enabling clients to integrate digital and AI transformations across diverse environments. The Consulting segment provides expertise in strategy, experience, technology, and operations across various industries, enhancing business processes. The Infrastructure segment delivers server, storage solutions, and lifecycle services for hybrid cloud environments, leveraging innovations like quantum computing. The Financing segment offers tailored financial solutions, facilitating clients access to IBMs products and services, thus supporting their technology adoption.
IBM has strategic partnerships with major companies such as Adobe, AWS, Microsoft, and SAP, enhancing its market reach and solution integration capabilities. Founded in 1911, IBM has evolved from manufacturing to a services and software-focused enterprise, headquartered in Armonk, New York.
3-Month Forecast:
Technically, IBMs stock is near the lower support level of 178.1. The SMA200 at 219.87 suggests a potential bullish trend if the price crosses above the SMA50 (248.69). The ATR of 9.05 indicates moderate volatility. Fundamentally, IBMs high P/E of 36.62 reflects market expectations for growth, supported by a forward P/E of 21.10. The RoE of 22% highlights efficient equity use.
If IBMs price breaks above 240.35 (SMA20), it may target the next resistance at 249.9. Conversely, a drop below 178.1 could lead to a downtrend. Investors should monitor these levels and partnership developments for potential opportunities.
Additional Sources for IBM Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
IBM Stock Overview
Market Cap in USD | 228,213m |
Sector | Technology |
Industry | Information Technology Services |
GiC Sub-Industry | IT Consulting & Other Services |
IPO / Inception | 1962-01-02 |
IBM Stock Ratings
Growth Rating | 95.0 |
Fundamental | 26.9 |
Dividend Rating | 57.8 |
Rel. Strength | 39.7 |
Analysts | 3.59/5 |
Fair Price Momentum | 298.74 USD |
Fair Price DCF | 275.61 USD |
IBM Dividends
Dividend Yield 12m | 2.12% |
Yield on Cost 5y | 5.30% |
Annual Growth 5y | 1.39% |
Payout Consistency | 97.3% |
IBM Growth Ratios
Growth Correlation 3m | -68.8% |
Growth Correlation 12m | 91.2% |
Growth Correlation 5y | 94.6% |
CAGR 5y | 21.87% |
CAGR/Max DD 5y | 1.07 |
Sharpe Ratio 12m | 1.44 |
Alpha | 46.32 |
Beta | 0.635 |
Volatility | 31.62% |
Current Volume | 3632.9k |
Average Volume 20d | 4238k |
What is the price of IBM stocks?
As of May 09, 2025, the stock is trading at USD 254.14 with a total of 3,632,924 shares traded.
Over the past week, the price has changed by +6.04%, over one month by +14.98%, over three months by +1.95% and over the past year by +54.61%.
As of May 09, 2025, the stock is trading at USD 254.14 with a total of 3,632,924 shares traded.
Over the past week, the price has changed by +6.04%, over one month by +14.98%, over three months by +1.95% and over the past year by +54.61%.
Is International Business a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, International Business is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 26.92 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IBM as of May 2025 is 298.74. This means that IBM is currently undervalued and has a potential upside of +17.55% (Margin of Safety).
Neither. Based on ValueRay Fundamental Analyses, International Business is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 26.92 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IBM as of May 2025 is 298.74. This means that IBM is currently undervalued and has a potential upside of +17.55% (Margin of Safety).
Is IBM a buy, sell or hold?
International Business has received a consensus analysts rating of 3.59. Therefor, it is recommend to hold IBM.
International Business has received a consensus analysts rating of 3.59. Therefor, it is recommend to hold IBM.
- Strong Buy: 8
- Buy: 2
- Hold: 9
- Sell: 1
- Strong Sell: 2
What are the forecast for IBM stock price target?
According to ValueRays Forecast Model, IBM International Business will be worth about 326.5 in May 2026. The stock is currently trading at 254.14. This means that the stock has a potential upside of +28.46%.
According to ValueRays Forecast Model, IBM International Business will be worth about 326.5 in May 2026. The stock is currently trading at 254.14. This means that the stock has a potential upside of +28.46%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 251.8 | -0.9% |
Analysts Target Price | 252.4 | -0.7% |
ValueRay Target Price | 326.5 | 28.5% |